TCI Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

TCI Wealth Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-154	Closed	-$15K	–	472
2023 Q1	$15K	Sell	154 -93	-38%	-$9.64K	﹤0.01%	851
2022 Q4	$25.6K	Buy	247 +100	+68%	+$9.39K	﹤0.01%	596
2022 Q3	$12K	Buy	147 +7	+5%	+$623	﹤0.01%	896
2022 Q2	$12K	Hold	140	–	–	﹤0.01%	887
2022 Q1	$11K	Sell	140 -37	-21%	-$3.1K	﹤0.01%	1024
2021 Q4	$16K	Buy	177 +15	+9%	+$1.24K	﹤0.01%	806
2021 Q3	$13K	Hold	162	–	–	﹤0.01%	906
2021 Q2	$14K	Buy	162 +30	+23%	+$2.38K	﹤0.01%	741
2021 Q1	$10K	Buy	132 +72	+120%	+$5.88K	﹤0.01%	843
2020 Q4	$5K	Hold	60	–	–	﹤0.01%	851
2020 Q3	$5K	Hold	60	–	–	﹤0.01%	751
2020 Q2	$7K	Hold	60	–	–	﹤0.01%	645
2020 Q1	$5K	Hold	60	–	–	﹤0.01%	699
2019 Q4	$5K	Hold	60	–	–	﹤0.01%	839
2019 Q3	$4K	Hold	60	–	–	﹤0.01%	851
2019 Q2	$5K	Hold	60	–	–	﹤0.01%	753
2019 Q1	$5K	Hold	60	–	–	﹤0.01%	772
2018 Q4	$5K	Hold	60	–	–	﹤0.01%	754
2018 Q3	$6K	Hold	60	–	–	﹤0.01%	734
2018 Q2	$6K	Hold	60	–	–	﹤0.01%	728
2018 Q1	$5K	Hold	60	–	–	﹤0.01%	724
2017 Q4	$5K	Hold	60	–	–	﹤0.01%	769
2017 Q3	$6K	Hold	60	–	–	﹤0.01%	688
2017 Q2	$5K	Hold	60	–	–	﹤0.01%	742
2017 Q1	$5K	Hold	60	–	–	﹤0.01%	704
2016 Q4	$5K	Buy	+60	New	+$5.16K	﹤0.01%	761
2016 Q1	–	Sell	-6	Closed	-$1K	–	1329
2015 Q4	$1K	Buy	+6	New	+$627	﹤0.01%	920

Other funds holding BMRN

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

TCI Wealth Advisors's BMRN Position: Q2 2023 in Review

TCI Wealth Advisors sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2023, closing a stake of 154 shares — an estimated $15K sold.

TCI Wealth Advisors first reported a position in BMRN in Q4 2015 and held it in 27 quarters. The position peaked at $25.6K in Q4 2022. 557 funds tracked by Wall St. Rank hold BMRN as of Q2 2023.

TCI Wealth Advisors reported no remaining BioMarin Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 154 BioMarin Pharmaceuticals shares in Q2 2023, an estimated $15K.
TCI Wealth Advisors first reported a position in BioMarin Pharmaceuticals in Q4 2015 and held it in 27 quarters.
TCI Wealth Advisors's BioMarin Pharmaceuticals position peaked at $25.6K in Q4 2022.
557 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.